First Report Managed Care

First Report Managed Care

443 Photos and videos

Tweets

First Report Managed Care @FirstReportMC

Apr 30

Happening today at 12 PM ET: join us live for expert perspectives on IgA nephropathy. This webinar will explore emerging therapies, access considerations, and key managed care implications in a rare and evolving disease state. Register now: hubs.ly/Q04cpTdD0

First Report Managed Care

First Report Managed Care @FirstReportMC

Apr 26

Happening this week: join us live on April 30 at 12 PM ET for expert perspectives on IgA nephropathy. This webinar will explore emerging therapies, access considerations, and key managed care implications in a rare and evolving disease state. Register: hubs.ly/Q04cpJMh0

First Report Managed Care

First Report Managed Care @FirstReportMC

Apr 23

1 week to go: Join us live on April 30 at 12 PM ET for expert perspectives on emerging therapies, access considerations, and managed care implications in IgA nephropathy. Register: hubs.ly/Q04cn67s0

First Report Managed Care

First Report Managed Care @FirstReportMC

Apr 19

Join Russell Spjut, PharmD and Matthew R. Weir, MD for expert perspectives on emerging therapies, access considerations, and managed care implications in IgA nephropathy. Live April 30 at 12 PM ET Register free: hubs.ly/Q04cn1rR0

First Report Managed Care

First Report Managed Care @FirstReportMC

Apr 16

Join us live on April 30 at 12 PM ET for a webinar on emerging therapies and managed care considerations in IgA nephropathy. Hear expert perspectives on access, evidence, and the evolving treatment landscape. Register now: hubs.ly/Q04cmZb70

First Report Managed Care

First Report Managed Care @FirstReportMC

7 Dec 2025

Don’t miss tomorrow’s live webinar! Join Dr Saad Ashraf as he discusses how nerandomilast, the first new idiopathic pulmonary fibrosis (IPF) therapy in over a decade, is transforming care and access. Free to register >>> hubs.ly/Q03X7jmr0

First Report Managed Care

First Report Managed Care @FirstReportMC

5 Dec 2025

Innovation in pulmonary fibrosis demands more than strategy. Hear from Dr Saad Ashraf on Monday, December 8 at 1 PM EST as he discusses how nerandomilast is redefining treatment and setting the stage for broader pulmonary fibrosis management. Register >>> hubs.ly/Q03WSQhz0

First Report Managed Care

First Report Managed Care @FirstReportMC

3 Dec 2025

How is new evidence changing pulmonary fibrosis care? Join Dr Saad Ashraf on Monday, December 8 at 1 PM EST for an expert discussion on nerandomilast and how it is shaping treatment decisions. Register for Free >>> hubs.ly/Q03WxVdw0

First Report Managed Care

First Report Managed Care @FirstReportMC

1 Dec 2025

First Report Managed Care

First Report Managed Care @FirstReportMC

29 Oct 2025

We’re going live tomorrow at 12:00 PM ET for our upcoming webinar From Innovation to Implementation: Rethinking Access in Idiopathic Pulmonary Fibrosis—will you be joining us? Secure your spot here! → hubs.ly/Q03MBrtz0

First Report Managed Care

First Report Managed Care @FirstReportMC

16 Oct 2025

Are you registered for the upcoming idiopathic pulmonary fibrosis webinar on October 30? Join Elizabeth Volkmann, MD, and Carole Tremonti, RN, MBA, to learn more about clinical innovation. hubs.ly/Q03MBkRd0

First Report Managed Care

First Report Managed Care @FirstReportMC

8 Oct 2025

As new therapies for idiopathic pulmonary fibrosis (IPF) emerge, healthcare stakeholders must navigate the balance between innovation and evidence-based coverage decisions. Register for this IPF webinar today! hubs.ly/Q03MBfHm0

First Report Managed Care

First Report Managed Care @FirstReportMC

8 Dec 2022

Study authors examined the safety and effectiveness of pitolisant in #patients with type I narcolepsy who did not tolerate or respond to previous treatments. buff.ly/3EJkOoL

First Report Managed Care

First Report Managed Care @FirstReportMC

5 Dec 2022

There's still time to register for the managed care considerations webinar on Addressing the Burdens of Alzheimer's Disease. Check out the two dates and times below! buff.ly/3iprwsF

First Report Managed Care

First Report Managed Care @FirstReportMC

4 Dec 2022

Researchers assessed potential factors driving differences in #disease burden between African American and White patients with multiple sclerosis. buff.ly/3GSLhDa

First Report Managed Care

First Report Managed Care @FirstReportMC

1 Dec 2022

Patients with relapsing/remitting multiple sclerosis reported improvements in #medication satisfaction, fatigue, and other measures after switching from other therapies to a monoclonal antibody. buff.ly/3OJabXL

First Report Managed Care

First Report Managed Care @FirstReportMC

30 Nov 2022

Happening soon! There's still time to register for today's webinar on managed care considerations for the treatment of tardive dyskinesia. Can't make it? Check out the other date below! buff.ly/3UzmQOt

First Report Managed Care

First Report Managed Care @FirstReportMC

30 Nov 2022

In the second part of this roundtable, Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss cost and access challenges for treating #patients with zanubrutinib. buff.ly/3EMxPQ2

First Report Managed Care

First Report Managed Care @FirstReportMC

29 Nov 2022

#ICYMI There is still time to register for tomorrow's Managed Care Considerations webinar happening at 1 p.m. buff.ly/3GU1pUX

First Report Managed Care

First Report Managed Care @FirstReportMC

27 Nov 2022

In addition to the #Economic burden of the disease, researchers also reported the humanistic burden associated with pediatric-onset multiple sclerosis. buff.ly/3i7Ri4B